Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS (R) hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain
- Resource Type
- Journal
- Source
PAIN PRACTICE ; JAN 2013, 13 1, p30-p40, 11p.- Subject
- Language
- English
- ISSN
- 15307085